Measuring endocannabinoid hydrolysis: Refining our tools and understanding

AAPS Journal

Volumn 11, Issue 2, 2009, Pages 307-311

  Marrs, William ^a   Stella, Nephi ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

ABHD12; ABHD6; Endocannabinoid; FAAH; MGL

Indexed keywords

ACYLGLYCEROL LIPASE; CAY 10499; ENDOCANNABINOID; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; PF 750; PIPERIDINE; UNCLASSIFIED DRUG;

COLORIMETRY; DRUG POTENCY; DRUG PURIFICATION; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME KINETICS; ENZYME SUBSTRATE; GENE EXPRESSION; GENE FUNCTION; HIGH THROUGHPUT SCREENING; HUMAN; HYDROLYSIS; HYDROPHOBICITY; NONHUMAN; SHORT SURVEY; SITE DIRECTED MUTAGENESIS;

AMIDOHYDROLASES; ANIMALS; ENDOCANNABINOIDS; HUMANS; HYDROLYSIS; KINETICS; MONOACYLGLYCEROL LIPASES; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION;

EID: 68249158220     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-009-9109-0     Document Type: Short Survey

References (38)

1. Devane WA, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 1992;258(5090):1946-9.
2. Horne EA, Stella N. The ins and outs of endocannabinoid signaling in healthy and diseased brain. Future Lipidology 2008;3(4):435-52.
3. McKinney MK, Cravatt BF. Structure and function of fatty acid amide hydrolase. Annu Rev Biochem. 2005;74:411-32.
4. Cravatt BF, et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A. 2001;98(16):9371-6.
5. Kathuria S, et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med. 2003;9(1):76-81.
6. Ahn K, McKinney MK, Cravatt BF. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev. 2008;108(5):1687-707.
7. Patricelli MP, Cravatt BF. Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase. Biochemistry. 2001;40(20):6107-15.
8. Bracey MH, et al. Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 2002;298(5599):1793-6.
9. Fegley D, et al. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): Effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther. 2005;313(1):352-8.
10. Zhang D, et al. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets. Neuropharmacology 2007;52(4):1095-105.
11. Liu Y, Patricelli MP, Cravatt BF. Activity-based protein profiling: The serine hydrolases. Proc Natl Acad Sci U S A. 1999;96(26):14694-9.
12. Barglow KT, Cravatt BF. Activity-based protein profiling for the functional annotation of enzymes. Nat Methods. 2007;4(10):822-7.
13. Ahn K, et al. Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity. Biochemistry 2007;46(45):13019-30.
14. Mileni M, et al. Structure-guided inhibitor design for human FAAH by interspecies active site conversion. Proc Natl Acad Sci U S A. 2008;105(35):12820-4.
15. Mechoulam R, et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995;50(1):83-90.
16. Sugiura T, et al. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog Lipid Res. 2006;45(5):405-46.
17. Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997;388(6644):773-8.
18. Katona I, Freund TF. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med. 2008;14(9):923-30.
19. Chevaleyre V, Takahashi KA, Castillo PE. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci. 2006;29:37-76.
20. Stella N. Endocannabinoid signaling in microglial cells. Neuropharmacology 2009;56(Suppl 1):244-53.
21. Dinh TP, et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A. 2002;99(16):10819-24.
22. Dinh TP, Kathuria S, Piomelli D. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol Pharmacol. 2004;66(5):1260-4.
23. Blankman JL, Simon GM, Cravatt BF. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol. 2007;14(12):1347-56.
24. Tornqvist H, Belfrage P. Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. J Biol Chem. 1976;251(3):813-9.
25. Saario SM, Laitinen JT. Monoglyceride lipase as an enzyme hydrolyzing 2-arachidonoylglycerol. Chem Biodivers. 2007;4(8):1903-13.
26. Karlsson M, et al. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J Biol Chem. 1997;272(43):27218-23.
27. Saario SM, et al. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. Chem Biol. 2005;12(6):649-56.
28. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226(1):497-509.
29. Muccioli GG, et al. Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. J Neurosci. 2007;27(11):2883-9.
30. Muccioli GG, Stella N. An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain. Anal Biochem. 2008;373(2):220-8.
31. Muccioli GG, Labar G, Lambert DM. CAY10499, a novel monoglyceride lipase inhibitor evidenced by an expeditious MGL assay. Chembiochem. 2008;9(16):2704-10.
32. Labar G, et al. Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling. Chembiochem. 2007;8(11):1293-7.
33. Wang Y, et al. A fluorescence-based assay for monoacylglycerol lipase compatible with inhibitor screening. Assay Drug Dev Technol. 2008;6(3):387-93.
34. Saario SM, et al. Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system. J Med Chem. 2006;49(15):4650-6.
35. Long JZ, et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol. 2009;5(1):37-44.
36. Marrs W, Stella N. 2-AG + 2 new players = forecast for therapeutic advances. Chem Biol. 2007;14(12):1309-11.
37. Hoover HS, et al. Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling. Bioorg Med Chem Lett. 2008;18(22):5838-41.
38. Li W, Blankman JL, Cravatt BF. A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. J Am Chem Soc. 2007;129(31):9594-5.